Chemistry 2011.org
Chemistry2011.org
All About Chemistry... 2011 and beyond

Related Stories

Tips on Seeking a Thyroid Surgeon, How to Improve Cancer Immunotherapy, Drug Combination Shuts Down Tumor Growth in Aggressive Lung Cancer, and more in the Cancer News Source

A new study provides insight on the potential role played by RNA (ribonucleic acid) editing in cancer.

–Boston University Medical Campus|2016-03-17

/images/uploads/2016/03/14/LoRoger.jpg

A new study by UCLA researchers has revealed how patterns of gene mutations and expression in a melanoma tumor before starting anti-PD-1 immunotherapy may forecast whether the tumor would shrink or the patient would derive survival benefits.

–University of California, Los Angeles (UCLA), Health Sciences|2016-03-17

/images/uploads/2016/03/15/RCas9_image_no_outlines.jpg

Scientists have long sought an efficient method for targeting RNA— intermediary genetic material that carries the Genetic-Code'>genetic code from the cell’s nucleus to protein-making machinery — in living cells. Researchers at University of California, San Diego School of Medicine have now achieved this by applying the popular DNA-editing technique CRISPR-Cas9 to RNA. The study is published March 17 in Cell.

–University of California, San Diego Health Sciences|2016-03-17

/images/uploads/2016/03/17/Buszczak_Carreira-Rosario_Bhargava.jpg

Researchers at UT Southwestern Medical Center have identified a second role for a class of RNA-binding proteins, revealing new insights about neurological diseases and conditions associated with this protein such as autism, epilepsy, and certain types of cancer.

–UT Southwestern Medical Center|2016-03-17

/images/uploads/2016/03/17/Mittendorf_E_sm.jpg

A new breast cancer staging system developed by researchers at The University of Texas MD Anderson Cancer Center finds that incorporating tumor biology is a critical prognostic indicator for women who undergo neoadjuvant, or pre-surgical, therapy for breast cancer.

–University of Texas M. D. Anderson Cancer Center|2016-03-17

Cancer cells have the ability to grow in an acidic tumor environment that is detrimental to other cells, including immune cells. In a Cancer Research cover article published this week, Moffitt Cancer Center reported that neutralizing the acidic tumor environment increases the efficacy of several immune-targeting cancer therapies.

–Moffitt Cancer Center |2016-03-17

/images/uploads/2016/03/17/ToorAmirsmall.jpg

Scientists at Virginia Commonwealth University have developed computer models that can simulate the recovery of the immune system in patients undergoing stem cell transplants.

–VCU Massey Cancer Center|2016-03-17

/images/uploads/2016/03/16/CoupsyellowrightNR0814.jpg

In December 2015, the FDA proposed new restrictions related to tanning bed use, including banning their use among individuals younger than 18. As the comment period on the proposal winds down, a Rutgers Cancer Institute of New Jersey investigator who conducts research on tanning behaviors weighs in.

–Rutgers Cancer Institute of New Jersey|2016-03-16

/images/uploads/2016/03/14/Cruciferous.jpg

Can we say goodbye to unreliable food diaries and diet recall in exchange for a urine test that will better aid researchers in figuring out what foods might help prevent cancer? Georgetown researchers have developed a method that can quickly evaluate specific food compounds in human urine.

–Georgetown Lombardi Comprehensive Cancer Center|2016-03-16

/images/uploads/2016/03/16/DNA_2.jpg

Research from Rutgers Cancer Institute of New Jersey examining difficult to treat tumors through genomic profiling shows that tumors with alterations in a signaling pathway responsible for cell regulation may respond to targeted therapy regardless of where the tumor originated in the body.

–Rutgers Cancer Institute of New Jersey|2016-03-16

A University of Houston researcher and his team have discovered an important link between alcohol and breast cancer by identifying a cancer-causing gene triggered by alcohol.

–University of Houston|2016-03-16

/images/uploads/2016/03/16/Hawk_E.jpg

The University of Texas MD Anderson Cancer Center brings its signature Making Cancer History® seminar to Midland, for the first time, 11:30 a.m. to 1:30 p.m., Tuesday, April 12, at the Midland Country Club, 6101 N. Highway 349.

–University of Texas M. D. Anderson Cancer Center|2016-03-16

New research finds improvement in overall survival rates among men with aggressive prostate cancer who were treated with radiation at a facility that frequently performs that treatment.

–Brigham and Women’s Hospital|2016-03-16

/images/uploads/2016/03/16/Ethan_Dmitrovsky_MD_sm.jpg

The American Society of Clinical Oncology (ASCO) will recognize two physician-scientists from The University of Texas MD Anderson Cancer Center with two of its highest distinctions at its annual meeting in Chicago.

–University of Texas M. D. Anderson Cancer Center|2016-03-16

The Cervix Cancer Research Network (CCRN) is working to facilitate clinical trials of treatments of cancer of the cervix in countries where the disease has a high burden and national research groups have not yet been established.

–Loyola University Health System|2016-03-16

Johns Hopkins scientists report they have developed an antibody against a specific cellular gateway that suppresses lung tumor cell growth and breast cancer metastasis in transplanted tumor experiments in mice, according to a new study published in the February issue of Nature Communications.

–Johns Hopkins Medicine|2016-03-16

Tips on Seeking a Thyroid Surgeon, How to Improve Cancer Immunotherapy, Drug Combination Shuts Down Tumor Growth in Aggressive Lung Cancer, and more in the Newswise Cancer News Source

– Newswise|2016-03-16

/images/uploads/2016/03/11/Levin_Oncotarget_tadpolewithlight.jpg

Tumors induced by oncogenes can be both prevented and normalized using light to control electric signaling among cells. The findings in frogs extend the application of optogenetics from neurons and the brain to cancer and provide proof of principle for a novel class of therapies which use light to override the action of oncogenic mutations.

–Tufts University|2016-03-16

Share this story with your friends!

Social Networking

Please recommend us on Facebook, Twitter and more:

Other social media tools

Global Partners
Feedback

Tell us what you think of Chemistry 2011 -- we welcome both positive and negative comments. Have any problems using the site? Questions?

About us

Chemistry2011 is an informational resource for students, educators and the self-taught in the field of chemistry. We offer resources such as course materials, chemistry department listings, activities, events, projects and more along with current news releases.

Events & Activities

Are you interested in listing an event or sharing an activity or idea? Perhaps you are coordinating an event and are in need of additional resources? Within our site you will find a variety of activities and projects your peers have previously submitted or which have been freely shared through creative commons licenses. Here are some highlights: Featured Idea 1, Featured Idea 2.

About you

Ready to get involved? The first step is to sign up by following the link: Join Here. Also don’t forget to fill out your profile including any professional designations.

Global Partners